Implanted PNS for Shoulder Pain in Stroke

植入 PNS 治疗中风肩痛

• 批准号: 8578038
• 负责人: John Chae
• 金额: $ 50.53万
• 依托单位: CASE WESTERN RESERVE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-06 至 2018-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8578038
• 关键词: Activities of Daily Living; Address; Adverse event; Affect; Anatomy; Arm Pain; Chronic; Clinical; Clinical Trials; Detection; Devices; Effectiveness; Electrodes; Enrollment; Equipment Malfunction; Exhibits; Future; Implant; Individual; Infection; Intervention; Intramuscular; Joints; Measures; Mediation; Motor; Outcome; Pain; Pain Threshold; Participant; Peripheral Nerve Stimulation; Peripheral Nerves; Phenotype; Physiological; Placebo Control; Population; Psychological Factors; Quality of life; Randomized; Randomized Controlled Trials; Reaction Time; Recovery; Refractory; Rehabilitation Outcome; Rehabilitation therapy; Review Literature; Role; Safety; Secondary Hyperalgesias; Sensory; Severities; Short-Term Course; Shoulder Pain; Site; Staging; Stroke; Subgroup; Survivors; System; Testing; Torque; arm; central sensitization; clinical practice; control trial; deltoid muscle; experience; improved; motor impairment; novel; post stroke; public health relevance; response; treatment effect

DESCRIPTION (provided by applicant): Shoulder pain following stroke is a major rehabilitation problem affecting approximately 60% of moderate to severely impaired stroke survivors. The investigative team demonstrated the efficacy of short-term, percutaneous intramuscular (IM) peripheral nerve stimulation (PNS) in treating shoulder pain following stroke. However, only those individuals who received treatment within 18 months of their stroke experienced enduring treatment effect. Those treated after 18 months experienced significant pain reduction at the end of treatment, but pain returned within 3 months. To treat this more challenging population, an exploratory placebo controlled, randomized controlled trial is proposed to demonstrate the safety and efficacy of a fully implantable PNS System. The trial has 2 stages. During the Trial Stage, participants who experience benefit from short-term percutaneous IM PNS, but in whom pain returns are identified. During the Implant Stage, these participants receive the fully implanted IM PNS system and are randomized to receive IM PNS or a second course of short-term percutaneous IM PNS treatment. Outcomes include pain, motor impairment, ADLs and quality of life. In order to explore mechanisms, participants in both Stages undergo quantitative sensory and motor testing.

描述（由申请人提供）：卒中后肩痛是一个主要的康复问题，影响约60%的中度至重度受损卒中幸存者。研究小组证明了短期经皮肌肉内（IM）周围神经刺激（PNS）治疗中风后肩痛的疗效。然而，只有那些在中风后18个月内接受治疗的人经历了持久的治疗效果。18个月后接受治疗的患者在治疗结束时疼痛明显减轻，但疼痛在3个月内复发。为了治疗这一更具挑战性的人群，拟定了一项探索性安慰剂对照、随机对照试验，以证明完全植入式PNS系统的安全性和有效性。审判分两个阶段。在试验阶段，受试者从短期经皮IM PNS中获益，但发现疼痛复发。在植入阶段，这些受试者接受完全植入的IM PNS系统，并随机接受IM PNS或短期经皮IM PNS治疗的第二个疗程。结局包括疼痛、运动障碍、ADL和生活质量。为了探索机制，两个阶段的参与者都要接受定量的感觉和运动测试。